Free Trial

Oaktree Acquisition Corp. III Life Sciences (OACC) Competitors

Oaktree Acquisition Corp. III Life Sciences logo
$10.44 -0.01 (-0.10%)
As of 07/3/2025 12:39 PM Eastern

OACC vs. ORC, NXRT, PAX, NOAH, AC, TINV, PLYM, GETY, AACT, and BRSP

Should you be buying Oaktree Acquisition Corp. III Life Sciences stock or one of its competitors? The main competitors of Oaktree Acquisition Corp. III Life Sciences include Orchid Island Capital (ORC), NexPoint Residential Trust (NXRT), Patria Investments (PAX), Noah (NOAH), Associated Capital Group (AC), Tiga Acquisition (TINV), Plymouth Industrial REIT (PLYM), Getty Images (GETY), Ares Acquisition Corporation II (AACT), and BrightSpire Capital (BRSP). These companies are all part of the "trading" industry.

Oaktree Acquisition Corp. III Life Sciences vs. Its Competitors

Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC) and Orchid Island Capital (NYSE:ORC) are both small-cap trading companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, institutional ownership, valuation, profitability, analyst recommendations, earnings, media sentiment and risk.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Oaktree Acquisition Corp. III Life Sciences
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Orchid Island Capital
0 Sell rating(s)
2 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

In the previous week, Orchid Island Capital had 1 more articles in the media than Oaktree Acquisition Corp. III Life Sciences. MarketBeat recorded 2 mentions for Orchid Island Capital and 1 mentions for Oaktree Acquisition Corp. III Life Sciences. Oaktree Acquisition Corp. III Life Sciences' average media sentiment score of 0.67 beat Orchid Island Capital's score of 0.53 indicating that Oaktree Acquisition Corp. III Life Sciences is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Oaktree Acquisition Corp. III Life Sciences
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Orchid Island Capital
0 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

32.7% of Orchid Island Capital shares are held by institutional investors. 0.4% of Orchid Island Capital shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Orchid Island Capital has higher revenue and earnings than Oaktree Acquisition Corp. III Life Sciences.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Oaktree Acquisition Corp. III Life SciencesN/AN/AN/AN/AN/A
Orchid Island Capital$241.58M3.59$37.66M$0.4017.88

Orchid Island Capital's return on equity of 1.52% beat Oaktree Acquisition Corp. III Life Sciences' return on equity.

Company Net Margins Return on Equity Return on Assets
Oaktree Acquisition Corp. III Life SciencesN/A N/A N/A
Orchid Island Capital N/A 1.52%0.17%

Summary

Orchid Island Capital beats Oaktree Acquisition Corp. III Life Sciences on 7 of the 8 factors compared between the two stocks.

Get Oaktree Acquisition Corp. III Life Sciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for OACC and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding OACC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

OACC vs. The Competition

MetricOaktree Acquisition Corp. III Life Sciences Industry SectorNASDAQ Exchange
Market Cap$234.13M$2.02B$2.00B$9.05B
Dividend YieldN/A13.74%13.71%4.03%
P/E RatioN/A12.3912.0220.22
Price / SalesN/A2,149,915.981,945,417.08118.64
Price / CashN/A1,960.261,147.2058.07
Price / BookN/A3.4510.525.67
Net IncomeN/A-$414.85M-$260.24M$249.13M
7 Day Performance-0.50%1.04%1.02%3.28%
1 Month Performance-0.76%2.83%2.78%5.55%
1 Year PerformanceN/A7.16%7.95%21.12%

Oaktree Acquisition Corp. III Life Sciences Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
OACC
Oaktree Acquisition Corp. III Life Sciences
N/A$10.44
-0.1%
N/AN/A$234.13MN/A0.00N/ANews Coverage
Positive News
ORC
Orchid Island Capital
4.0663 of 5 stars
$7.07
-0.4%
N/A-14.2%$859.39M$241.58M17.662,018News Coverage
High Trading Volume
NXRT
NexPoint Residential Trust
4.8804 of 5 stars
$33.21
+0.2%
$43.58
+31.2%
-12.0%$838.44M$259.70M-25.953Positive News
High Trading Volume
PAX
Patria Investments
2.3142 of 5 stars
$13.72
-0.4%
$14.00
+2.0%
+14.8%$832.00M$390.10M27.44390High Trading Volume
NOAH
Noah
3.3705 of 5 stars
$12.01
-2.4%
$12.00
-0.1%
+43.2%$814.53M$356.33M12.381,990Positive News
Gap Down
AC
Associated Capital Group
1.9524 of 5 stars
$37.62
-0.1%
N/A+15.0%$795.83M$13.18M21.0220
TINV
Tiga Acquisition
N/A$22.40
+1.6%
N/A+89.3%$772.80MN/A0.00N/AHigh Trading Volume
PLYM
Plymouth Industrial REIT
4.0284 of 5 stars
$16.12
-1.6%
$21.10
+30.9%
-24.0%$746.08M$198.35M5.2940Analyst Upgrade
High Trading Volume
GETY
Getty Images
2.9013 of 5 stars
$1.72
-2.0%
$4.35
+153.6%
-44.1%$723.48M$939.29M-9.031,700Analyst Upgrade
Analyst Revision
High Trading Volume
AACT
Ares Acquisition Corporation II
N/A$11.30
0.0%
N/A+5.8%$699.02MN/A0.00N/A
BRSP
BrightSpire Capital
3.0215 of 5 stars
$5.26
-0.1%
$7.15
+36.1%
-9.9%$686.23M$244.77M-9.3850News Coverage

Related Companies and Tools


This page (NASDAQ:OACC) was last updated on 7/5/2025 by MarketBeat.com Staff
From Our Partners